Scynexis (SCYX) Consolidated Net Income (2013 - 2026)

Scynexis (SCYX) posted Consolidated Net Income of -$16.4 million for Q1 2026, down 234.03% on a QoQ basis from $12.3 million in Q4 2025, and down 204.75% year-over-year from $15.7 million in Q1 2025.

Scynexis (SCYX) Consolidated Net Income (2013 - 2026) Analysis & Trends

Scynexis' Consolidated Net Income history runs 13 years deep, the most recent figure standing at -$16.4 million for Q1 2026.

  • Quarterly Consolidated Net Income fell 204.75% year-over-year to -$16.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$19.6 million (up 27.61% YoY) and the FY2025 annual result came in at -$8.6 million, up 59.65% from the prior year.
  • Consolidated Net Income was -$16.4 million for Q1 2026 at Scynexis, down from $12.3 million in the prior quarter.
  • Across five years, Consolidated Net Income topped out at $122.3 million in Q2 2023 and bottomed at -$33.9 million in Q1 2023.
  • A 5-year average of -$2.9 million and a median of -$6.9 million in 2025 frame the typical range for Consolidated Net Income.
  • Annual changes were most pronounced in 2022 — Consolidated Net Income plunged 4789.92% — and 2023, when it soared 1016.15%.
  • Scynexis' Consolidated Net Income stood at -$19.5 million in 2022, then dropped by 9.06% to -$21.3 million in 2023, then surged by 78.92% to -$4.5 million in 2024, then surged by 373.49% to $12.3 million in 2025, then plunged by 234.03% to -$16.4 million in 2026.
  • Business Quant data shows SCYX's Consolidated Net Income at -$16.4 million in Q1 2026, $12.3 million in Q4 2025, and -$8.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Haleon 89.46 Bn 87.60 Bn - -
2 Teva Pharmaceutical Industries 35.98 Bn 32.24 Bn 1.97 Bn 370.00 Mn
3 Zoetis 32.62 Bn 30.68 Bn 1.62 Bn 601.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -3.58 Bn
5 United Therapeutics 23.05 Bn 20.90 Bn 648.10 Mn 274.90 Mn
6 RedHill Biopharma 21.48 Bn 21.48 Bn - -
7 Viatris 20.27 Bn 18.47 Bn 1.16 Bn 176.40 Mn
8 Neurocrine Biosciences 17.78 Bn 16.47 Bn 800.70 Mn 197.90 Mn
9 Elanco Animal Health 12.63 Bn 12.20 Bn 785.00 Mn 57.00 Mn
10 Scynexis 23.44 Mn -13.31 Mn - -16.43 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -16.43 Mn
Dec 31, 2025 12.26 Mn
Sep 30, 2025 -8.59 Mn
Jun 30, 2025 -6.89 Mn
Mar 31, 2025 -5.39 Mn
Dec 31, 2024 -4.48 Mn
Sep 30, 2024 -2.81 Mn
Jun 30, 2024 -14.46 Mn
Mar 31, 2024 411,000.00
Dec 31, 2023 -21.27 Mn
Sep 30, 2023 -1.76 Mn
Jun 30, 2023 122.26 Mn
Mar 31, 2023 -33.88 Mn
Dec 31, 2022 -19.50 Mn
Sep 30, 2022 -29.58 Mn
Jun 30, 2022 -13.35 Mn
Mar 31, 2022 -5.45 Mn
Dec 31, 2021 -29.28 Mn
Sep 30, 2021 -605,000.00
Jun 30, 2021 1.66 Mn